SMCI Form 4: Tuan Sherman Sells 255,786 Shares, Gets 9,048 Options
Tuan Sherman, a director of Super Micro Computer, Inc. (SMCI), reported a sale of 255,786 common shares and the grant of 9,048 stock options on 08/08/2025.
Rhea-AI Filing Summary
Tuan Sherman, a director of Super Micro Computer, Inc. (SMCI), reported a sale of 255,786 common shares and the grant of 9,048 stock options on 08/08/2025. The options carry a stated exercise price of $44.6 and were granted for service in fiscal 2026. Per the filing, the options will fully vest and become exercisable on June 30, 2026, with pro rata vesting if the reporting person’s service ends earlier. The options cover 9,048 underlying common shares if exercised. The Form 4 discloses the disposition and the compensatory option award but does not provide reasons for the sale.
Positive
- 9,048 stock options granted as explicit compensatory alignment for fiscal 2026 service
- Options carry a clear vesting schedule: fully vest and become exercisable on June 30, 2026, with pro rata vesting if service ends earlier
Negative
- Disposition of 255,786 common shares reported, representing a material insider sale in absolute share count
- Filing does not state the reason or proceeds for the sale, limiting insight into the motivation behind the transaction
Insights
TL;DR: Director sold 255,786 shares and received 9,048 options; options vest mid-2026.
The filing shows a large insider disposition combined with a compensatory equity award. The 255,786-share disposal is a clear change in reported holdings, while the 9,048 options at an exercise price of $44.6 establish potential future dilution equal to the underlying shares if exercised. The explicit vesting date of June 30, 2026 ties the grant to service through fiscal 2026, aligning compensation with continued service. The filing does not state the sale proceeds or reason, which limits interpretation of intent.
TL;DR: Routine compensatory option grant with defined vesting, offset by a sizable share disposition by a director.
The disclosure documents a standard director compensation mechanism—an option grant with a clear vesting schedule—intended to align the director’s incentives with the company’s future performance. Simultaneously, the director reported a substantial sale (255,786 shares), which reduces insider ownership on record. Because the filing supplies the grant size, exercise price, and vesting terms but not transaction rationale, investors cannot infer motivation beyond the facts reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 9,048 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The stock options were granted with respect to service to be provided by the Reporting Person to SMCI in fiscal 2026. The total number of stock options will fully vest and become exercisable on June 30, 2026; provided, however, that if the Reporting Person's service to SMCI ends before June 30, 2026, then a pro rata number of stock options will vest and become exercisable based upon service provided from July 1, 2025 to the last day of service.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tuan Sherman report on the SMCI Form 4?
When do the granted SMCI options vest and become exercisable?
Who reported the transaction for SMCI?
AI-generated analysis. How Rhea-AI works. Not financial advice.